Skip to main content
Erschienen in: European Journal of Nutrition 6/2021

02.02.2021 | Original Contribution

The effects of Chlorella supplementation on glycemic control, lipid profile and anthropometric measures on patients with type 2 diabetes mellitus

verfasst von: Amir Mehdi Hosseini, Seyed Ali Keshavarz, Ensieh Nasli-Esfahani, Fatemehsadat Amiri, Leila Janani

Erschienen in: European Journal of Nutrition | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Diabetes is a chronic disease and the prevalence of it is rapidly increasing. Recently, the use of natural products in chronic diseases such as diabetes has gained more attention. Chlorella, a single-celled green alga, is one of them. There have been some studies on the effects of chlorella supplementation in chronic diseases such as NAFLD, prediabetes, and diabetic mice, but none of them examined the effects of chlorella in patients with T2DM. The present study was designed to evaluate the effects of chlorella supplementation on glycemic control, lipid profile, and anthropometric indices in type 2 diabetic patients.

Methods

This study is a double-blind, randomized controlled trial. 84 patients with T2DM assigned into two groups, receiving 1500 mg/day C. vulgaris or placebo for 8 weeks. Anthropometric information, blood pressure, 24-h food intake recall, and blood samples were collected at the beginning and end of the study to determine the changes of FBS, HbA1c, insulin concentration, insulin resistance, and lipid profile.

Results

None of the variables investigated in this study showed a significant change after 8 weeks of intervention with C. vulgaris.

Conclusion

According to the findings of this study, supplementation with C. vulgaris with a dosage of 1500 mg/day for 8 weeks, does not improve the anthropometric measurements, glycemic status, and lipid profile as well. Thus, it cannot be considered as a complementary therapeutic approach to common medications at this dosage and duration. However, future studies with a higher dosage of C. vulgaris and more prolonged than 8 weeks are needed to be done.
Literatur
1.
Zurück zum Zitat Egan AM, Dinneen SF (2019) What is diabetes? Medicine (United Kingdom). 47:1–4 Egan AM, Dinneen SF (2019) What is diabetes? Medicine (United Kingdom). 47:1–4
2.
Zurück zum Zitat Punthakee Z, Goldenberg R, Katz P. (2018) Definition, classification and diagnosis of diabetes , prediabetes and metabolic syndrome diabetes Canada clinical practice guidelines expert committee. Can J Diabetes 42:S10–5. Available from: https://doi.org/https://doi.org/10.1016/j.jcjd.2017.10.003 Punthakee Z, Goldenberg R, Katz P. (2018) Definition, classification and diagnosis of diabetes , prediabetes and metabolic syndrome diabetes Canada clinical practice guidelines expert committee. Can J Diabetes 42:S10–5. Available from: https://​doi.​org/​https://​doi.​org/​10.​1016/​j.​jcjd.​2017.​10.​003
3.
Zurück zum Zitat Krebs N, Jacobson M, Cradock M, Pihoker C, Raymer T, Shiffman RN, et al. (2001) Children, adolescents, and television. Pediatrics [cited 2019 Jun 11];107(2):423–6. Available from: http://pediatrics.aappublications.org/cgi/doi/https://doi.org/10.1542/peds.107.2.423 Krebs N, Jacobson M, Cradock M, Pihoker C, Raymer T, Shiffman RN, et al. (2001) Children, adolescents, and television. Pediatrics [cited 2019 Jun 11];107(2):423–6. Available from: http://​pediatrics.​aappublications.​org/​cgi/​doi/​https://​doi.​org/​10.​1542/​peds.​107.​2.​423
5.
Zurück zum Zitat Forouzanfar MH, Afshin A, Alexander LT, Anderson HR, Bhutta ZA, Biryukov S, et al. (2016) Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet [cited 2019 May 18]; 388(10053):1659–724. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27733284 Forouzanfar MH, Afshin A, Alexander LT, Anderson HR, Bhutta ZA, Biryukov S, et al. (2016) Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet [cited 2019 May 18]; 388(10053):1659–724. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​27733284
7.
Zurück zum Zitat Lee HS, Park HJ, Kim MK (2008) Effect of Chlorella vulgaris on lipid metabolism in Wistar rats fed high fat diet. Nutr Rsearch Pract 2:204–210CrossRef Lee HS, Park HJ, Kim MK (2008) Effect of Chlorella vulgaris on lipid metabolism in Wistar rats fed high fat diet. Nutr Rsearch Pract 2:204–210CrossRef
8.
Zurück zum Zitat Jong-Yuh C, Mei-Fen S (2005) Potential hypoglycemic effects of Chlorella in streptozotocin-induced diabetic mice. Life Sci 77(9):980–990CrossRef Jong-Yuh C, Mei-Fen S (2005) Potential hypoglycemic effects of Chlorella in streptozotocin-induced diabetic mice. Life Sci 77(9):980–990CrossRef
9.
Zurück zum Zitat Han JG, Kang GG, Kim JK, Sangjin K (2002) The present status and future of Chlorella. Food Sci Ind 6:64–69 Han JG, Kang GG, Kim JK, Sangjin K (2002) The present status and future of Chlorella. Food Sci Ind 6:64–69
10.
Zurück zum Zitat Cherng JY, Shih MF (2006) Improving glycogenesis in Streptozocin (STZ) diabetic mice after administration of green algae Chlorella. Life Sci 78(11):1181–1186CrossRef Cherng JY, Shih MF (2006) Improving glycogenesis in Streptozocin (STZ) diabetic mice after administration of green algae Chlorella. Life Sci 78(11):1181–1186CrossRef
12.
Zurück zum Zitat Shibata S, Natori Y, Nishihara T, Tomisaka K, Matsumoto K, Sansawa H, et al. (2003) Antioxidant and anti-cataract effects of Chlorella on rats with streptozotocin-induced diabetes. J Nutr Sci Vitaminol (Tokyo) [cited 2019 May 29];49(5):334–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14703308 Shibata S, Natori Y, Nishihara T, Tomisaka K, Matsumoto K, Sansawa H, et al. (2003) Antioxidant and anti-cataract effects of Chlorella on rats with streptozotocin-induced diabetes. J Nutr Sci Vitaminol (Tokyo) [cited 2019 May 29];49(5):334–9. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​14703308
13.
14.
Zurück zum Zitat Guzmán S, Gato A, Lamela M, Freire-Garabal M, Calleja JM. (2003) Anti-inflammatory and immunomodulatory activities of polysaccharide from Chlorella stigmatophora and Phaeodactylum tricornutum. Phyther Res [cited 2019 May 29];17(6):665–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12820237 Guzmán S, Gato A, Lamela M, Freire-Garabal M, Calleja JM. (2003) Anti-inflammatory and immunomodulatory activities of polysaccharide from Chlorella stigmatophora and Phaeodactylum tricornutum. Phyther Res [cited 2019 May 29];17(6):665–70. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​12820237
15.
Zurück zum Zitat Hasegawa T, Tanaka K, Ueno K, Ueno S, Okuda M, Yoshikai Y, et al. (1989) Augmentation of the resistance against Escherichia coli by oral administration of a hot water extract of Chlorella vulgaris in rats. Int J Immunopharmacol [cited 2019 May 29];11(8):971–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2693376 Hasegawa T, Tanaka K, Ueno K, Ueno S, Okuda M, Yoshikai Y, et al. (1989) Augmentation of the resistance against Escherichia coli by oral administration of a hot water extract of Chlorella vulgaris in rats. Int J Immunopharmacol [cited 2019 May 29];11(8):971–6. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​2693376
16.
Zurück zum Zitat Ebrahimi-Mameghani M, Sadeghi Z, Abbasalizad Farhangi M, Vaghef-Mehrabany E, Aliashrafi S (2016) Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: beneficial effects of supplementation with microalgae Chlorella vulgaris: a double-blind placebo-controlled randomized clinical trial. Clin Nutr 36:1001–1006CrossRef Ebrahimi-Mameghani M, Sadeghi Z, Abbasalizad Farhangi M, Vaghef-Mehrabany E, Aliashrafi S (2016) Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: beneficial effects of supplementation with microalgae Chlorella vulgaris: a double-blind placebo-controlled randomized clinical trial. Clin Nutr 36:1001–1006CrossRef
18.
Zurück zum Zitat Noguchi N, Konishi F, Kumamoto S, Maruyama I, Ando Y, Yanagita T. (2003) Beneficial effects of Chlorella on glucose and lipid metabolism in obese rodents on a high-fat diet. Obes Res Clin Pract 7(2):e95–105. Available from: http://dx.doi.org/https://doi.org/10.1016/j.orcp.2013.01.002 Noguchi N, Konishi F, Kumamoto S, Maruyama I, Ando Y, Yanagita T. (2003) Beneficial effects of Chlorella on glucose and lipid metabolism in obese rodents on a high-fat diet. Obes Res Clin Pract 7(2):e95–105. Available from: http://​dx.​doi.​org/​https://​doi.​org/​10.​1016/​j.​orcp.​2013.​01.​002
19.
Zurück zum Zitat Vecina JF, Oliveira AG, Araujo TG, Baggio SR, Torello CO, Saad MJA, et al. (2014) Chlorella modulates insulin signaling pathway and prevents high-fat diet-induced insulin resistance in mice. Life Sci 95(1):45–52. Available from: http://dx.doi.org/https://doi.org/10.1016/j.lfs.2013.11.020 Vecina JF, Oliveira AG, Araujo TG, Baggio SR, Torello CO, Saad MJA, et al. (2014) Chlorella modulates insulin signaling pathway and prevents high-fat diet-induced insulin resistance in mice. Life Sci 95(1):45–52. Available from: http://​dx.​doi.​org/​https://​doi.​org/​10.​1016/​j.​lfs.​2013.​11.​020
20.
Zurück zum Zitat Ebrahimi-Mameghani M, Aliashrafi S, Javadzadeh Y, AsghariJafarabadi M. (2014) The effect of Chlorella vulgaris supplementation on liver en-zymes, serum glucose and lipid profile in patients with non-alcoholic fatty liver disease. Heal Promot Perspect 4(1):107–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25097844 Ebrahimi-Mameghani M, Aliashrafi S, Javadzadeh Y, AsghariJafarabadi M. (2014) The effect of Chlorella vulgaris supplementation on liver en-zymes, serum glucose and lipid profile in patients with non-alcoholic fatty liver disease. Heal Promot Perspect 4(1):107–15. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​25097844
22.
24.
Zurück zum Zitat Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab [cited 2019 Jun 2]; 85(7):2402–10. Available from: https://academic.oup.com/jcem/article-lookup/doi/https://doi.org/10.1210/jcem.85.7.6661 Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab [cited 2019 Jun 2]; 85(7):2402–10. Available from: https://​academic.​oup.​com/​jcem/​article-lookup/​doi/​https://​doi.​org/​10.​1210/​jcem.​85.​7.​6661
25.
Zurück zum Zitat Ebrahimi-Mameghani M, Sadeghi Z, Abbasalizad Farhangi M, Vaghef-Mehrabany E, Aliashrafi S (2017) Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: beneficial effects of supplementation with microalgae Chlorella vulgaris: a double-blind placebo-controlled randomized clinical trial. Clin Nutr 36(4):1001–1006CrossRef Ebrahimi-Mameghani M, Sadeghi Z, Abbasalizad Farhangi M, Vaghef-Mehrabany E, Aliashrafi S (2017) Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: beneficial effects of supplementation with microalgae Chlorella vulgaris: a double-blind placebo-controlled randomized clinical trial. Clin Nutr 36(4):1001–1006CrossRef
26.
Zurück zum Zitat Panahi Y, Pishgoo B, Jalalian HR, Mohammadi E, Taghipour HR, Sahebkar A et al (2012) Investigation of the effects of Chlorella vulgaris as an adjunctive therapy for dyslipidemia: results of a randomised open-label clinical trial. Nutr Diet 69(1):13–19CrossRef Panahi Y, Pishgoo B, Jalalian HR, Mohammadi E, Taghipour HR, Sahebkar A et al (2012) Investigation of the effects of Chlorella vulgaris as an adjunctive therapy for dyslipidemia: results of a randomised open-label clinical trial. Nutr Diet 69(1):13–19CrossRef
27.
Zurück zum Zitat Panahi Y, Ghamarchehreh ME, Beiraghdar F, Zare R, Jalalian HR, Sahebkar A (2012) Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial. Hepatogastroenterology. [cited 2019 Aug 7]; 59(119):2099–103. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23234816 Panahi Y, Ghamarchehreh ME, Beiraghdar F, Zare R, Jalalian HR, Sahebkar A (2012) Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial. Hepatogastroenterology. [cited 2019 Aug 7]; 59(119):2099–103. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​23234816
28.
Zurück zum Zitat Haidari F, Homayouni F, Helli B, Haghighizadeh MH, Farahmandpour F (2018) Effect of chlorella supplementation on systematic symptoms and serum levels of prostaglandins, inflammatory and oxidative markers in women with primary dysmenorrhea. Eur J Obstet Gynecol Reprod Biol 229:185–9. Available from: https://doi.org/https://doi.org/10.1016/j.ejogrb.2018.08.578 Haidari F, Homayouni F, Helli B, Haghighizadeh MH, Farahmandpour F (2018) Effect of chlorella supplementation on systematic symptoms and serum levels of prostaglandins, inflammatory and oxidative markers in women with primary dysmenorrhea. Eur J Obstet Gynecol Reprod Biol 229:185–9. Available from: https://​doi.​org/​https://​doi.​org/​10.​1016/​j.​ejogrb.​2018.​08.​578
30.
Zurück zum Zitat Fallah AA, Sarmast E, Habibian Dehkordi S, Engardeh J, Mahmoodnia L, Khaledifar A, et al. (2018) Effect of Chlorella supplementation on cardiovascular risk factors: A meta-analysis of randomized controlled trials. Clin Nutr 37(6):1892–901. Available from: https://doi.org/https://doi.org/10.1016/j.clnu.2017.09.019 Fallah AA, Sarmast E, Habibian Dehkordi S, Engardeh J, Mahmoodnia L, Khaledifar A, et al. (2018) Effect of Chlorella supplementation on cardiovascular risk factors: A meta-analysis of randomized controlled trials. Clin Nutr 37(6):1892–901. Available from: https://​doi.​org/​https://​doi.​org/​10.​1016/​j.​clnu.​2017.​09.​019
31.
Zurück zum Zitat Merchant RE, Andre CA, Sica DA. (2002) Nutritional supplementation with Chlorella pyrenoidosa for mild to moderate hypertension. J Med Food [cited 2019 Aug 30]; 5(3):141–52. Available from: http://www.liebertpub.com/doi/https://doi.org/10.1089/10966200260398170 Merchant RE, Andre CA, Sica DA. (2002) Nutritional supplementation with Chlorella pyrenoidosa for mild to moderate hypertension. J Med Food [cited 2019 Aug 30]; 5(3):141–52. Available from: http://​www.​liebertpub.​com/​doi/​https://​doi.​org/​10.​1089/​1096620026039817​0
33.
Zurück zum Zitat Mizoguchi T, Takehara I, Masuzawa T, Saito T, Naoki Y (2008) Nutrigenomic Studies of Effects of Chlorella on Subjects with High-Risk Factors for Lifestyle-Related Disease. J Med Food 11(3):395–404. Available from: http://www.liebertonline.com/doi/abs/https://doi.org/10.1089/jmf.2006.0180 Mizoguchi T, Takehara I, Masuzawa T, Saito T, Naoki Y (2008) Nutrigenomic Studies of Effects of Chlorella on Subjects with High-Risk Factors for Lifestyle-Related Disease. J Med Food 11(3):395–404. Available from: http://​www.​liebertonline.​com/​doi/​abs/​https://​doi.​org/​10.​1089/​jmf.​2006.​0180
35.
Zurück zum Zitat Jeong H, Kwon HJ, Kim MK (2009) Hypoglycemic effect of Chlorella vulgaris intake in type 2 diabetic Goto-Kakizaki and normal Wistar rats. Nutr Res Pract 3:23–30CrossRef Jeong H, Kwon HJ, Kim MK (2009) Hypoglycemic effect of Chlorella vulgaris intake in type 2 diabetic Goto-Kakizaki and normal Wistar rats. Nutr Res Pract 3:23–30CrossRef
36.
Zurück zum Zitat Ryu NH, Lim Y, Park JE, Kim J, Kim JY, Kwon SW, et al. (2014) Impact of daily Chlorella consumption on serum lipid and carotenoid profiles in mildly hypercholesterolemic adults: A double-blinded, randomized, placebo-controlled study. Nutr J [Internet] 13(1). Available from:https://pubmed.ncbi.nlm.nih.gov/24920270/ Ryu NH, Lim Y, Park JE, Kim J, Kim JY, Kwon SW, et al. (2014) Impact of daily Chlorella consumption on serum lipid and carotenoid profiles in mildly hypercholesterolemic adults: A double-blinded, randomized, placebo-controlled study. Nutr J [Internet] 13(1). Available from:https://​pubmed.​ncbi.​nlm.​nih.​gov/​24920270/​
Metadaten
Titel
The effects of Chlorella supplementation on glycemic control, lipid profile and anthropometric measures on patients with type 2 diabetes mellitus
verfasst von
Amir Mehdi Hosseini
Seyed Ali Keshavarz
Ensieh Nasli-Esfahani
Fatemehsadat Amiri
Leila Janani
Publikationsdatum
02.02.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 6/2021
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-021-02492-5

Weitere Artikel der Ausgabe 6/2021

European Journal of Nutrition 6/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.